Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
about
The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemiasImmunochemical detection of proteins related to the human c-myc exon 1Chromosomal localisation of the human homologues to the oncogenes erbA and BSite-specific integration by adeno-associated virusIdentification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virusNucleotide sequence analysis of the proviral genome of avian myelocytomatosis virus (MC29)Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-mycRetroviral oncogenes: a historical primerProviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomasCharacterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogeneHIV-1 promotor insertion revealed by selective detection of chimeric provirus-host gene transcriptsHuman adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structureHuman DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virusIdentification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activitybic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNAFunctional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesisEvaluation of the chicken transcriptome by SAGE of B cells and the DT40 cell lineTwo endogenous retroviral loci appear to contribute to Multiple SclerosisWhat history tells us XXXV. Enhancers: their existence and characteristics have raised puzzling issues since their discoverySeptin Mutations in Human CancersIdentification of cancer genes by mutational profiling of tumor genomesCellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomasDilute-coat-color locus of mice: nucleotide sequence analysis of the d+2J and d+Ha revertant allelesInhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migrationChemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on CarcinogensMutagenesis of avian carcinoma virus MH2: only one of two potential transforming genes (delta gag-myc) transforms fibroblastsAvian myeloblastosis virus and E26 virus oncogene products are nuclear proteinsRetroviruses and cancer: models for cancer in animals and humans.Genetic screens in mammalian cells by enhanced retroviral mutagens.Pvt1-encoded microRNAs in oncogenesis.Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis.Retroviral sequences in rheumatoid arthritis synovium.The saga of XMRV: a virus that infects human cells but is not a human virus.myc protooncogene linked to retroviral promoter, but not to enhancer, transforms embryo cells.NICER elements: a family of nerve growth factor-inducible cAMP-extinguishable retrovirus-like elements.PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.Endogenous retroviral long terminal repeats within the HLA-DQ locus.Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice.Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA.
P2860
Q24339375-7A612C67-6855-4A20-A807-F3B9F5DDC92AQ24531841-A4F283CD-00E4-4EB9-BFFE-8D6AA68ECB59Q24555649-F3A0F198-4D08-4615-9AC2-4F7BDA7D24E8Q24558738-A2DFE731-EC3A-41D3-A801-78720810905DQ24559244-F842D747-A083-4B1C-B87B-00715B06113BQ24600456-7121BAE9-EDDE-4A45-9996-5685205337CEQ24600729-D3D9AB1F-818F-4DE3-9C58-0C5D5B2847B0Q24611142-C72ECB64-C7D7-4E97-BBAE-59B09810C091Q24614782-E8D37F0E-C22B-4F89-9211-2C828C7D5B3FQ24615673-B20CADFA-4878-4EC9-94F3-E3C57BFDC240Q24628751-2F429C07-E07C-44AE-B0C9-77FD102140B4Q24628886-EE378441-C817-48E6-AA60-023E53E7105FQ24630798-3E01E9B4-905D-4E6E-8D86-65A5AAF657ACQ24632239-F428F5BD-4560-4C64-B751-45EA4E0612EFQ24647092-215F7BA3-359D-45E2-BE64-F1733354CE34Q24682989-F9C0673D-BE43-4A19-91B1-277D136547C7Q24798620-49115FF2-6014-475F-96C6-37C5195CC8ABQ26748841-38E2C982-5F6E-4BBF-9201-68B5C5C1D9D6Q27022909-6C5BFEF7-FC15-4D31-A60B-1BE5D44AE909Q28078227-7DF58999-20F0-497F-BFAE-4D0A0F97DFD3Q28239452-0B3A6F62-5139-46DE-8F37-549A738AB6F5Q28270474-32A39B8B-1A71-4DC9-B04A-F981AE8F6D3EQ28507562-283648FF-8A51-4ABC-95E8-3CAE9C4CDD8DQ28579985-375B3DAD-6549-464B-8C02-200C234E2C39Q28768656-173B9318-F5FF-4844-B790-E99AF3A75FACQ28775977-65AEE95A-6FF1-4E4C-8804-1D6B199CC292Q28776270-6534DA99-3780-42C1-AC4D-3F0C9B8F038BQ30467457-49E5F8CA-4228-44AC-9F6F-774040B72C63Q30645249-604C5282-929E-4F97-A155-097780F1F94DQ33345075-BA325E17-E5AB-4AEE-9054-AC425758E03CQ33352699-61CF44DE-D1F4-4EB1-BB2A-0ADD51676739Q33536187-58F03F90-9C78-400D-9238-F56888FB6A78Q33561230-7D720765-4387-4933-9E00-707035BF4D58Q33569248-A92752C1-BD28-4DAA-BAB8-49C97F96BD4DQ33584938-13CFE021-01B7-4F93-9ABD-7204ED8446CFQ33610890-0B1353AB-BE2A-4E89-A8C4-AA177ACDD9A2Q33648866-376B66A3-049E-438B-A4D6-F2457FE51AA2Q33652644-5183FEE1-608C-47F7-830F-6DF40C489CC8Q33654203-EB9F464F-487E-43AF-9D98-704B50728EE1Q33655796-F13A7185-AC2A-4A3E-97B4-458B64B3B2C1
P2860
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@en
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@nl
type
label
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@en
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@nl
prefLabel
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@en
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@nl
P2093
P2860
P356
P1433
P1476
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.
@en
P2093
P2860
P2888
P304
P356
10.1038/290475A0
P407
P577
1981-04-01T00:00:00Z
P5875
P6179
1010217685